Nephrotic syndrome: vizsgálatok itt: Egyesült Királyság
4 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Where
- Leicester, Oxford, Salford
- Életkor
- 16 év to 75 év
- People
- 84 worldwide
- Run by
- Sanofi
See details and how to joinNCT06500702 - 2. fázisTaking peopleStudy of WAL0921 in Patients With Glomerular Kidney Diseases
- Where
- Derby, Leicester, London, Manchester, Salford
- Életkor
- 18 év to 75 év
- People
- 96 worldwide
- Run by
- Walden Biosciences
See details and how to joinNCT06466135 - 2. fázisTaking peopleStudy of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Where
- Bristol, Glasgow, Liverpool, London, Manchester
- Életkor
- 1 év to 17 év
- People
- 67 worldwide
- Run by
- Travere Therapeutics, Inc.
See details and how to joinNCT05003986 · EU 2023-505497-14-00 - No phaseTaking peopleNational Registry of Rare Kidney Diseases
- Where
- Bristol
- People
- 35 000
- Run by
- UK Kidney Association
See details and how to joinNCT06065852